Back

PCSK9 inhibition in patients without previous cardiovascular events but at high risk: the earlier the better

European Heart Journal

26 June 2026
Organised by: Logo
Read full article
ESC Journals PREVENTIVE CARDIOLOGY Risk Factors and Prevention

Contributors

David Sinning
David Sinning

Author

Ulf Landmesser
Ulf Landmesser

Author

Charite University Hospital Berlin , Germany

You may be interested in
thumbnail
Congress Presentation
Evaluating risk-based allocation strategies for PCSK9 inhibitors: results from a simulation study in a contemporary ASCVD cohort
26 August 2023
thumbnail
Congress Presentation
NATURE-LEGACY: Long term legacy benefit of Lowering LDL and SBP
1 September 2025
thumbnail
Congress Presentation
PCSK9 inhibitors and incidence of arrhythmias in clinical practice: a phase IV multicentric study
18 April 2023
thumbnail
Webinar
Risk assessment and lipid management in primary prevention
11 April 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources